Since physiological concentrations (0.1-1 pM) of adenosine influence the functions of human polymorphonuclear neutrophils (PMNs), we investigated the metabolism of adenosine in suspensions of stimulated and unstimulated PMNs. Stimulation with phorbol myristate acetate (PMA, 1 MM), but not by zymosan (0.5 mg/ml) or N-formyl-methionyl-leucyl-phenylalanine (fMLP, 1 MM), provoked an accumulation of endogenous adenosine at a rate of 23±1.0 amol/cell per minute. A similar accumulation was observed with both unstimulated and stimulated PMNs after the addition of deoxycoformycin (dCF, 1-100 MM), an inhibitor of adenosine deaminase. Exogenous adenosine (10 MM) was deaminated at a rate of 9.8±3.7 amol/ cell per minute in control or zymosan or fMLP-stimulated PMN suspensions. This deamination was nearly completely suppressed when the PMNs had been stimulated with PMA. In contrast, the activity of adenosine deaminase in PMN lysates (231±72 amol/cell per minute) was not modified by PMA stimulation. a,#-Methyleneadenosine 5'-diphosphate (AMPCP, 2.5 mM), an inhibitor of membranous ecto-5'-nucleotidase, profoundly inhibited endogenous adenosine accumulation under all conditions. PMA stimulation also provoked an inactivation of extracellular adenosine d purine nucleoside phosphorylase, and lactate dehydrogenase in PMN suspensions. We concluded that PMNs, even when not stimulated, continuously produce adenosine by dephosphorylation of extracellularly released adenylates; and that stimulation of PMNs by PMA causes adenosine accumulation owing to the inactivation of adenosine deaminase released by broken cells. (J. Clin. Invest. 1991. 87:305-312.)
uli are inhibited, whereas chemotaxis is enhanced (4) . These effects have been shown to involve adenosine receptors (4) (5) (6) (7) . Adenosine might thus be a physiologically important inhibitor of PMN-mediated cell injury (4, 8) .
Adenosine is an intermediate of the catabolism of the adenine nucleotides. These are maintained in equilibrium by adenylate kinase, and ultimately broken down to hypoxanthine in most human cell types, including PMNs (Fig. 1) . Adenine nucleotide catabolism can occur by two pathways that differ in two metabolic steps. The branchpoint is at AMP, which can either be dephosphorylated to adenosine by 5'-nucleotidase(s), or deaminated to inosine 5'-monophosphate (IMP)' by AMP deaminase. The adenosine formed along the right-hand pathway does not necessarily accumulate, as it can be either rephosphorylated to AMP by adenosine kinase (9) , or deaminated to inosine by adenosine deaminase (ADA). IMP, formed along the left-hand pathway, is dephosphorylated to inosine, most likely by a different 5'-nucleotidase than that which acts on AMP (10, 11) . Purine nucleoside phosphorylase (PNP) splits inosine into hypoxanthine and ribose 1-P.
Phagocytic stimuli are known to induce ATP breakdown in PMNs (12) (13) (14) . Although the presence of adenosine in suspensions of human PMNs has been documented (1, 15) , little additional information is available with respect to production, uptake, and degradation, and the resulting accumulation of adenosine by these cells, at rest and upon stimulation. In this work, the catabolic pathway ofthe adenine nucleotides and the accumulation of adenosine have been studied in detail in suspensions of human PMNs, incubated under resting conditions and in the presence ofthe following stimuli: zymosan, a particulate extract from yeast; N-formyl-methionyl-leucyl-phenylalanine (fMLP), a chemotactic peptide; and phorbol myristate acetate (PMA), a stimulator of protein kinase C. Our results show that stimulation of PMNs by PMA provokes an extracellular accumulation of adenosine due to inactivation of ADA released by the cells. Adenosine formed by the PMNs themselves might thus inhibit their capacity to injure cells.
Methods
Materials. Nucleotides, nucleosides, bases, and auxiliary enzymes were from Boehringer GmbH (Mannheim, FRG). (sp act = 58 Ci/mol), [8-14C] AMP (55 Ci/mol), [8-'4C] Belle (Janssen Research, Beerse, Belgium). Bromododecane (BDD) was from Janssen Chimica, Beerse The supernate was discarded and the cells resuspended in 1 ml KRB by repeated aspiration in an automatic pipettip. A hemolytic shock was performed by adding 42 ml bidistilled H20, followed after 20 s by 14 ml NaCl 3.5%. After centrifugation (5 min, 200 g), the cells were washed three times with 20 ml KRB and centrifuged 5 min at 150, 100, and 60 g, respectively. The cells obtained in this way were typically > 93% PMNs, and viability, as judged by trypan blue exclusion, was > 96%.
Incubations. Cell suspensions, containing between 3 and 60* 106 cells/ml, were incubated in KRB at 250C, in siliconized glass liquid scintillation vials, in a shaking water bath. Care was taken to provide sufficient flushing with 95% 02, 5% Co2. For determinations of metabolites in the total cell suspension, 400 AI total incubation medium was pipetted into 100 Ml ice-cold 10% perchloric acid (PCA) at the times indicated. After centrifugation at 10,000 g for 3 min, 460 M1 of the supernate was transferred into a conical Eppendorf tube and neutralized with 100 Al of a neutralization mixture containing KOH 1.08 M, KHCO3 1.08 M, and bromthymol blue 77 MM.
When cells and extracellular medium had to be separated, the method of Cornell (16) was used, adapted as follows. 400 Ml BDD was layered on top of 200 Ml PCA 10% in a conical Eppendorf tube. 500 M1 PMN suspension was carefully layered on top of the BDD. Care was taken to avoid having the first drop penetrate the BDD layer and consequently to come in contact with the PCA. The tubes were centrifuged I min at 10,000 g. Up to 400 MI of supernate could be recovered by using a 100-Ml automatic pipette, and frozen in C02/acetone for enzyme analysis and/or added to PCA (4 vol of supernate to I vol of PCA 10%) and neutralized after 30 min by adding 1 vol ofthe mixture given above. After carefully removing the remaining supernate, as well as the major part of the BDD, the precipitate was resuspended with a plastic rod, recentrifuged (3 min, 10,000 g), and 140 Ml of the PCA layer was transferred to another Eppendorf tube containing 100 Ml of the neutralization mixture given above.
For determination of the catabolism of adenosine in the total cell suspension, [8-'4C] adenosine (10 Comparison of the concentrations of hypoxanthine in the incubation medium and in the total cell suspension showed that they were always the same, as was the case for adenosine. This indicates that these metabolites did not accumulate inside the cells. Inosine, on the other hand, was found to accumulate markedly in the total cell suspension but not in the extracellular medium under those conditions in which an important ATP breakdown was observed, namely in the presence of PMA or 2-deoxyglucose. This was confirmed by measuring inosine inside the cells after centrifugation through BDD. As shown in Fig. 5 , inosine accumulated strongly intracellularly within 10 min after PMA and 2-deoxyglucose, and still > 70% of total inosine was found intracellularly at the end of the incubation. This suggests that both intracellular phosphorolysis of inosine to hypoxanthine by PNP and transport of inosine out of the PMNs became rate-limiting when ATP breakdown was markedly accelerated. The sum of intra and extracellular purine catabolites accounted for the loss of ATP after PMA or 2-deoxyglucose.
Metabolism ofexogenous adenosine
Adenosine, added at the concentration of 10 uM to control PMN suspensions, was deaminated at the rate of 9.8±3.7 The absence of appreciable penetration ofadenosine inside the PMNs was confirmed by the observation that the addition of the inhibitors of nucleoside transport, dipyridamole and soluflazin (both at 10 AM), had no effect on the rate of degradation of exogenous adenosine (10 Influence ofinhibition ofadenosine deaminase To obtain further insights in the pathway ofthe degradation of the adenine nucleotides and in the mechanism of the accumulation of adenosine induced by PMA, experiments were performed with dCF, a potent, tight binding inhibitor of ADA (21) . In the presence of 1 gM dCF the deamination of 10 ,uM ["4C]adenosine by control PMN suspensions was completely inhibited (< 0.1 amol/cell per minute, n = 5). Addition of 1 juM dCF to the cell suspension, incubated in control conditions or in the presence ofzymosan, fMLP, or 2-deoxyglucose, induced a similar accumulation of adenosine as that observed upon addition of PMA in the absence ofdCF (Fig. 4) . Addition of dCF (1 or 100 MM) together with PMA did not significantly alter the adenosine accumulation as compared to dCF or PMA alone (Table I ). These results indicate that adenosine is produced by the PMNs under control conditions but that the nucleoside does not accumulate owing to deamination by ADA; and that this production is not modified by fMLP, zymosan, 2-deoxyglucose, or PMA. The data also confirm the previous suggestion that the adenosine accumulation induced by PMA is caused by inhibition or inactivation of ADA.
ADA in lysates obtained from cells incubated for 0, 7, 15, or 42 min with 1 MM dCF and washed three times before lysis was not inhibited. This indicates that, similar to adenosine and inosine, the inosine analogue dCF does not penetrate inside the PMNs. This result also confirms the previous suggestion that the accumulation ofadenosine induced by PMA is caused by an effect on extracellular ADA. When PMN suspensions were incubated for 0, 7, 15, or 42 min in the presence of 100 MM dCF, intracellular ADA assayed in lysates prepared after three washes of the cells was inhibited by 95% (results not shown). That the inhibition was already recorded at 0 min suggests that it was not caused by penetration ofdCF inside the cells, but rather by an artifact as, e.g., adsorption of the inhibitor on the cell membrane, followed by release during the sonication procedure.
Neither the changes in endogenous adenosine or any ofthe other metabolites monitored, nor the disappearance rate of exogenous adenosine were affected in any of the conditions studied by adding 5-iodotubercidin, an inhibitor of adenosine kinase. This is most probably due to lack of transport of 5-iodotubercidin, a nucleoside analogue.
Effect ofinhibitors ofectonucleotidases
The results described hitherto clearly indicated that the adenosine production, leading to adenosine accumulation in the presence of PMA or dCF, was due to extracellular degradation by ectonucleotidases of nucleotides released in the medium, rather than to intracellular catabolism of AMP by cytosolic To further substantiate the PMA-induced inactivation of extracellularly released ADA, its activity in the incubation medium was measured at various intervals over the whole duration of the experiments. As shown in Fig. 6 A, about 3% of the total activity of ADA was in the extracellular medium at the beginning of the incubations. This proportion increased slowly and approximately linearly to around 9% after 52 min under control conditions as well as upon stimulation with zymosan or fMLP (not illustrated). Addition of PMA provoked a rapid inactivation of ADA, which persisted over the duration of the experiment. These findings prompted an evaluation of the influence of incubation and of the addition of PMA on PNP, another enzyme of purine catabolism, and on LDH, a classical index of cellular integrity. Fig. 6 , B and C show that the progressive accumulation of extracellular ADA recorded under control conditions was also found for PNP and LDH. These rates of accumulation were also not influenced by the addition of zymosan or fMLP (not illustrated). The overall release of the three enzymes over the duration of the experiments was 7±2%, which is close to the loss of ATP in control conditions (Fig. 2) . Similar to ADA, PNP and LDH were also inactivated by the addition of PMA, although inactivation of LDH was slower and not as pronounced as that of ADA or PNP.
Discussion
In accordance with others (12-14), we have observed that the phagocytic stimuli, zymosan, fMLP, and PMA, and the inhibitor of glycolysis, 2-deoxyglucose, induce catabolism ofATP in human PMNs. Our studies demonstrate that this intracellular catabolism proceeds, at least in part, via AMP deaminase, by the left-hand pathway depicted in Fig. 1 . This leads to an intracellular accumulation of IMP and inosine, followed by the release of hypoxanthine in the extracellular medium (Fig.  7) . In addition, we have found that suspensions of human PMNs continuously form adenosine at a fixed rate, both at rest and upon stimulation. This formation occurs extracellularly from adenine nucleotides released by the cells. It does not lead to accumulation of adenosine, unless the fraction of ADA which is released extracellularly is inhibited by dCF or inactivated by stimulation of the cells with PMA. The intra-and extracellular catabolism of adenine nucleotides in suspensions of human PMNs, the PMA-induced accumulation of adenosine, and information obtained with respect to the nucleoside transport system in these cells will be discussed separately.
Intracellular catabolism ofadenine nucleotides
The decrease in ATP, induced in PMNs by stimuli ofphagocytosis, has been explained by the extra amount of energy required for this process (12, 23 Whether catabolism of AMP also proceeds via its intracellular dephosphorylation to adenosine could not be determined, owing to the absence ofpenetration ofthe ADA inhibitor, dCF, inside the PMNs. The absence of penetration of both dCF and 5-iodotubercidin also precluded the determination of the existence of a futile recycling of adenosine, as demonstrated in isolated rat hepatocytes (9 (29) and ecto-ADPase(s) (30) present on human PMN membranes. Indeed, addition of AMPCP, which we also found inhibitory of the latter ecto-enzymes, increased the extracellular concentration of ATP and ADP, but not that of AMP. The observation that ADA was found in medium from which the PMNs had been separated indicates, however, that ADA was released from the cells rather than present as an ecto-enzyme on their outer membrane. The extracellular release of adenine nucleotides is most likely due to unavoidable cell breakage during the incubations. This is indicated by the observation that, in control conditions, the loss of ATP and the release of ADA, PNP, and LDH occurred in parallel. In addition, the rate of adenosine formation in the presence ofdCF or PMA in its turn corresponded to the loss of ATP in control conditions. The absence of modifications of the release of adenine nucleotides under the various experimental conditions indicates that these did not influence cell breakage. The constant rate of release of nucleotides also explains why the rates ofaccumulation ofadenosine were similar when ADA was inhibited or inactivated. Cell breakage may nevertheless be a normal event in PMNs, and the accompanying release of adenosine may play a role in combination with ADA inactivation, as discussed in the next paragraph.
Adenosine accumulation following stimulation with PMA As evidenced by the disappearance of the adenosine-deaminating activity from the incubation medium, the striking accumulation of adenosine observed upon stimulation of the PMNs with PMA results from inhibition of adenosine catabolism. The nearly complete loss of ADA activity in the incubation medium upon stimulation with PMA, together with the absence of effect ofthis medium on the ADA activity liberated upon lysis of the total suspension, argues against the generation of an ADA inhibitor by the PMNs upon PMA stimulation. Rather, it sustains the hypothesis that extracellular ADA is inactivated by intact, stimulated cells. This inactivation is most likely explained by the PMA-induced activation, by way of protein kinase C, of the bactericidal mechanisms of the PMNs. Why the other phagocytic stimuli, zymosan and fMLP, which also activate the bactericidal mechanisms, did not inactivate ADA, might be explained by several factors such as the more pronounced and longer lasting production of superoxide induced by PMA as compared with zymosan or fMLP (31, 32) , or the more selective release, provoked by PMA, of the specific granules of PMNs (33) . As yet it cannot be ruled out, however, that in certain pathophysiological conditions, in which the number of PMNs per unit volume of extracellular fluid is higher than in our experiments, stimulation of PMNs with natural stimuli might result in extracellular adenosine accumulation.
The inactivation ofthe three enzymes assayed (ADA, PNP, and LDH) suggests that the inactivation of extracellularly released enzymes by PMA-stimulated PMNs might be a general feature, but whether or not it is mediated by a common mechanism can only be found out by more directed experiments. The small difference in the shape of the inactivation curves between ADA and PNP on one side and LDH on the other side might indicate the operation of several inactivation mechanisms having distinct affinities for the different enzymes.
The significance of the inactivation of ADA and other enzymes by PMA is not immediately apparent. Since adenosine inhibits PMN-induced tissue injury (8) , it may be one of the mechanisms whereby protein kinase C exerts its general, protective role against cellular overstimulation (34) . The PMAinduced accumulation ofadenosine in PMN suspensions most likely accounts for the insensitivity to adenosine of the PMAinduced generation of superoxide (1, 35) .
As evidenced by our data, extracellular LDH activity (and probably other enzyme activities as well) may not be used as a parameter of cell integrity of PMNs, at least not when stimulated with PMA.
Nucleoside transport
The marked rise of intracellular inosine recorded in association with high rates ofATP breakdown, without an equivalent increase in extracellular inosine, indicates that the nucleoside transporter is poorly efficient in the human PMN membrane. Other observations corroborate this conclusion: (a) the 25-fold lower rate ofdegradation of adenosine in suspensions of intact PMNs as compared with cell lysates; (b) the absence ofeffect of inhibitors of adenosine transport on the rate of degradation of exogenous adenosine; (c) the absence of incorporation of labeled adenosine into the nucleotides of intact PMNs, although adenosine kinase was found in PMN lysates; and (d) the lack of penetration of 1 ,uM dCF, a nucleoside analogue, inside the PMNs. To our knowledge, transport of nucleosides has not been investigated in detail in human PMNs. Cronstein et al. (1) have shown that 0.1 M adenosine, a 100-fold lower concentration than the one we used, disappeared from the incubation medium of PMNs and that this disappearance could be inhibited by dipyridamole. At up to 0.5 ,uM adenosine little or no radioactivity was, however, found incorporated into adenine nucleotides (1) . This suggests that low concentrations of adenosine may have been adsorbed on the cell membrane, similar to what we observed with dCF. Our results thus indicate that, in contrast to rabbit PMNs (36), but similar to sheep and dog erythrocytes (37) , human PMNs may only have a poorly efficient, low capacity nucleoside transport system. That the formation ofadenosine induced by 2-deoxyglucose in rat PMNs proceeded intracellularly and was accompanied by an increase in AMP (38) further indicates that important species differences exist with respect to the metabolic characteristics of PMNs.
